Olema Pharmaceuticals, Inc. ($OLMA)
Filing Information
| Accession Number | 0001831216-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 5, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
356,250
Total Value
$0.00
P&L
+inf% (+$5,240,437.50)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CH. DISCOV. & NON-CLIN DEV OFF | Stock Option (Right to Buy) | Derivative | Feb 2, 2026 | Grant/Award | 250,000 | $0.00 | $0.00 | 250,000 | Direct | โ | View Details | |
CH. DISCOV. & NON-CLIN DEV OFF | Performance Stock Options (Right to Buy) | Derivative | Feb 2, 2026 | Grant/Award | 106,250 | $0.00 | $0.00 | 106,250 | Direct | โ | View Details |